Evidence map›Paper›PMID 37066270›Full record

ArticleResearch square2023

Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy.

Lubna Naaz Chaudhary, Julie Jorns, Yunguang Sun, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind, MaryBeth Gonyo, Amanda Kong, Caitlin Patten, Tina Yen and 11 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 1 country.

Lubna Naaz ChaudharyMedical College of Wisconsin.ORCID 0000-0003-0616-6135
Julie JornsMedical College of Wisconsin.
Yunguang SunMedical College of Wisconsin.
Yee Chung ChengMedical College of Wisconsin.
Sailaja KamarajuMCW: Medical College of Wisconsin.
John BurfeindMCW: Medical College of Wisconsin.
MaryBeth GonyoMCW: Medical College of Wisconsin.
Amanda KongMCW: Medical College of Wisconsin.
Caitlin PattenMCW: Medical College of Wisconsin.
Tina YenMCW: Medical College of Wisconsin.
Chandler CortinaMCW: Medical College of Wisconsin.
Ebony CarsonMCW: Medical College of Wisconsin.
Nedra JohnsonMCW: Medical College of Wisconsin.
Carmen BergomMCW: Medical College of Wisconsin.
Shirng-Wern TsaihMCW: Medical College of Wisconsin.
Anjishnu BanerjeeMCW: Medical College of Wisconsin.
Yu WangMCW: Medical College of Wisconsin.
Inna ChervonevaThomas Jefferson University.
Elizabeth WeilMCW: Medical College of Wisconsin.
Christopher R ChitambarMCW: Medical College of Wisconsin.
Hallgeir RuiMCW: Medical College of Wisconsin.
Medical College of Wisconsin · USThomas Jefferson University · US

Funding

Institutional Career Development CoreKL2TR001438 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI WIDLANSKY, MICHAEL E · 2015 to 2024
$2.9M
WNT pathway-driven anti-estrogen therapy resistance in breast cancerR01CA267549 · NCI · THOMAS JEFFERSON UNIVERSITY · PI Inna Chervoneva, Hallgeir Rui · 2023 to 2026
$2.2M
Quantitative Analyses of HER2 Upregulation in Luminal Breast Cancer in Response to Neoadjuvant Endocrine TherapyR03CA259594 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI CHAUDHARY, LUBNA N., RUI, HALLGEIR · 2021 to 2022
$170k
NCATS NIH HHS KL2 TR001438NCI NIH HHS R01 CA267549NCI NIH HHS R03 CA259594
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37066270
PMCPMC10104267
OpenAlexW4362701379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.